Vitrolife AB (publ) (STO:VITR)
Sweden
· Delayed Price · Currency is SEK 92.05
-1.60 (-1.71%)
Mar 9, 2026, 5:29 PM CET
Vitrolife AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 3,440 | 3,609 | 3,512 | 3,234 | 1,681 | Upgrade
|
| Revenue Growth (YoY) | -4.68% | 2.76% | 8.60% | 92.38% | 34.96% | Upgrade
|
| Cost of Revenue | 1,443 | 1,470 | 1,534 | 1,454 | 635 | Upgrade
|
| Gross Profit | 1,997 | 2,139 | 1,978 | 1,780 | 1,046 | Upgrade
|
| Selling, General & Admin | 1,318 | 1,232 | 1,117 | 1,002 | 503 | Upgrade
|
| Research & Development | 118 | 117 | 127 | 143 | 114 | Upgrade
|
| Other Operating Expenses | 5,396 | -1 | -4 | -12 | - | Upgrade
|
| Operating Expenses | 6,832 | 1,348 | 1,240 | 1,133 | 617 | Upgrade
|
| Operating Income | -4,835 | 791 | 738 | 647 | 429 | Upgrade
|
| Interest Expense | -51 | -98 | -94 | -44 | -10 | Upgrade
|
| Interest & Investment Income | - | 24 | 16 | 2 | 1 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -30 | -64 | -34 | 41 | Upgrade
|
| Other Non Operating Income (Expenses) | 1 | -10 | -5 | -16 | -1 | Upgrade
|
| EBT Excluding Unusual Items | -4,885 | 677 | 591 | 555 | 460 | Upgrade
|
| Impairment of Goodwill | - | - | -4,250 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -4 | -3 | -23 | - | Upgrade
|
| Asset Writedown | - | - | -50 | - | - | Upgrade
|
| Pretax Income | -4,885 | 674 | -3,712 | 537 | 460 | Upgrade
|
| Income Tax Expense | 127 | 160 | 139 | 143 | 116 | Upgrade
|
| Earnings From Continuing Operations | -5,012 | 514 | -3,851 | 394 | 344 | Upgrade
|
| Minority Interest in Earnings | - | -1 | - | - | -3 | Upgrade
|
| Net Income | -5,012 | 513 | -3,851 | 394 | 341 | Upgrade
|
| Net Income to Common | -5,012 | 513 | -3,851 | 394 | 341 | Upgrade
|
| Net Income Growth | - | - | - | 15.54% | 18.88% | Upgrade
|
| Shares Outstanding (Basic) | 135 | 135 | 135 | 135 | 115 | Upgrade
|
| Shares Outstanding (Diluted) | 135 | 136 | 135 | 135 | 115 | Upgrade
|
| Shares Change (YoY) | -0.07% | 0.09% | - | 18.12% | 5.60% | Upgrade
|
| EPS (Basic) | -37.01 | 3.79 | -28.44 | 2.91 | 2.97 | Upgrade
|
| EPS (Diluted) | -37.01 | 3.78 | -28.44 | 2.91 | 2.97 | Upgrade
|
| EPS Growth | - | - | - | -2.18% | 12.58% | Upgrade
|
| Free Cash Flow | 365 | 815 | 690 | 585 | 359 | Upgrade
|
| Free Cash Flow Per Share | 2.69 | 6.01 | 5.10 | 4.32 | 3.13 | Upgrade
|
| Dividend Per Share | 1.100 | 1.100 | 1.000 | 0.850 | 0.800 | Upgrade
|
| Dividend Growth | - | 10.00% | 17.65% | 6.25% | - | Upgrade
|
| Gross Margin | 58.05% | 59.27% | 56.32% | 55.04% | 62.22% | Upgrade
|
| Operating Margin | -140.55% | 21.92% | 21.01% | 20.01% | 25.52% | Upgrade
|
| Profit Margin | -145.70% | 14.21% | -109.65% | 12.18% | 20.29% | Upgrade
|
| Free Cash Flow Margin | 10.61% | 22.58% | 19.65% | 18.09% | 21.36% | Upgrade
|
| EBITDA | 949 | 1,167 | 1,107 | 991 | 506 | Upgrade
|
| EBITDA Margin | 27.59% | 32.34% | 31.52% | 30.64% | 30.10% | Upgrade
|
| D&A For EBITDA | 5,784 | 376 | 369 | 344 | 77 | Upgrade
|
| EBIT | -4,835 | 791 | 738 | 647 | 429 | Upgrade
|
| EBIT Margin | -140.55% | 21.92% | 21.01% | 20.01% | 25.52% | Upgrade
|
| Effective Tax Rate | - | 23.74% | - | 26.63% | 25.22% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.